X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice.
AuthorsMitchell, Jacqueline C
Ariff, Belall B
Yates, Darran M
Perkinton, Michael S
Stephenson, John D
Miller, Christopher C J
McLoughlin, Declan M
AffiliationMRC Centre for Neurodegeneration Research, King's College London, Institute of Psychiatry, London SE5 8AF, UK.
Amyloid beta-Protein Precursor
Disease Models, Animal
Mice, Inbred C57BL
Nerve Tissue Proteins
MetadataShow full item record
CitationX11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice. 2009, 18 (23):4492-500 Hum. Mol. Genet.
JournalHuman molecular genetics
AbstractIncreased production and deposition of amyloid beta-protein (Abeta) are believed to be key pathogenic events in Alzheimer's disease. As such, routes for lowering cerebral Abeta levels represent potential therapeutic targets for Alzheimer's disease. X11beta is a neuronal adaptor protein that binds to the intracellular domain of the amyloid precursor protein (APP). Overexpression of X11beta inhibits Abeta production in a number of experimental systems. However, whether these changes to APP processing and Abeta production induced by X11beta overexpression also induce beneficial effects to memory and synaptic plasticity are not known. We report here that X11beta-mediated reduction in cerebral Abeta is associated with normalization of both cognition and in vivo long-term potentiation in aged APPswe Tg2576 transgenic mice that model the amyloid pathology of Alzheimer's disease. Overexpression of X11beta itself has no detectable adverse effects upon mouse behaviour. These findings support the notion that modulation of X11beta function represents a therapeutic target for Abeta-mediated neuronal dysfunction in Alzheimer's disease.
- The neuronal adaptor protein X11beta reduces amyloid beta-protein levels and amyloid plaque formation in the brains of transgenic mice.
- Authors: Lee JH, Lau KF, Perkinton MS, Standen CL, Rogelj B, Falinska A, McLoughlin DM, Miller CC
- Issue date: 2004 Nov 19
- The X11 proteins, Abeta production and Alzheimer's disease.
- Authors: Miller CC, McLoughlin DM, Lau KF, Tennant ME, Rogelj B
- Issue date: 2006 May
- The neuronal adaptor protein X11alpha reduces Abeta levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice.
- Authors: Lee JH, Lau KF, Perkinton MS, Standen CL, Shemilt SJ, Mercken L, Cooper JD, McLoughlin DM, Miller CC
- Issue date: 2003 Nov 21
- Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
- Authors: Dutescu RM, Li QX, Crowston J, Masters CL, Baird PN, Culvenor JG
- Issue date: 2009 Sep
- Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
- Authors: Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z
- Issue date: 2011 Sep 23